{"database": "openregs", "table": "federal_register", "rows": [["2019-26971", "Product-Specific Guidance for Cocaine Hydrochloride; Nasal Solution; New Draft Guidance for Industry; Availability", "Notice", "The Food and Drug Administration (FDA, Agency, or we) is announcing the availability of a new draft guidance for industry, entitled \"Draft Guidance for Cocaine Hydrochloride.\" The new draft guidance, when finalized, will provide product-specific recommendations on, among other things, the information and data needed to demonstrate bioequivalence (BE) to support abbreviated new drug applications (ANDAs) for a cocaine hydrochloride nasal solution.", "2019-12-16", 2019, 12, "https://www.federalregister.gov/documents/2019/12/16/2019-26971/product-specific-guidance-for-cocaine-hydrochloride-nasal-solution-new-draft-guidance-for-industry", "https://www.govinfo.gov/content/pkg/FR-2019-12-16/pdf/2019-26971.pdf", "Health and Human Services Department; Food and Drug Administration", "221,199", "The Food and Drug Administration (FDA, Agency, or we) is announcing the availability of a new draft guidance for industry, entitled \"Draft Guidance for Cocaine Hydrochloride.\" The new draft guidance, when finalized, will provide product-specific...", null]], "columns": ["document_number", "title", "type", "abstract", "publication_date", "pub_year", "pub_month", "html_url", "pdf_url", "agency_names", "agency_ids", "excerpts", "regulation_id_numbers"], "primary_keys": ["document_number"], "primary_key_values": ["2019-26971"], "units": {}, "query_ms": 88.35048601031303, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}